MedPath
FDA Approval

KO-LANTA

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 31, 2025
Labeling Type
HUMAN OTC DRUG LABEL
Dimethicone(20 mg in 5 mL)
Aluminum hydroxide(200 mg in 5 mL)
Magnesium hydroxide(200 mg in 5 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

GCP Laboratories

965480861

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

GCP Laboratories

Geri-Care Pharmaceuticals, Corp

GCP Laboratories

965480861

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

KO-LANTA

Product Details

NDC Product Code
57896-004
Application Number
M001
Marketing Category
OTC Monograph Drug (C200263)
Route of Administration
ORAL
Effective Date
March 31, 2025
BUTYLPARABENInactive
Code: 3QPI1U3FV8Class: IACT
HYDROXYETHYL CELLULOSE, UNSPECIFIEDInactive
Code: T4V6TWG28DClass: IACT
Code: 92RU3N3Y1OClass: ACTIBQuantity: 20 mg in 5 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OHClass: IACT
SORBITOL SOLUTIONInactive
Code: 8KW3E207O2Class: IACT
Code: 5QB0T2IUN0Class: ACTIBQuantity: 200 mg in 5 mL
Code: NBZ3QY004SClass: ACTIBQuantity: 200 mg in 5 mL
© Copyright 2025. All Rights Reserved by MedPath